Product Information

AMLODIPINE BESYLATE 2.5 MG TAB is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.0113 per EA under NDC 76282050790. Its NADAC has been published 135 times since Apr 24, 2024.

FDA first approved this application on Dec 10, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE BESYLATE 2.5 MG TAB

Amlodipine besylate
$0.0113per EA

Strength

2.5 mg/1

NDC

76282050790

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

AMLODIPINE BESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA206367

FDA Approved

12/10/2015

TE Code

AB

On Market Since

3/15/2022

Pharmacological Classes

Calcium Channel Antagonists
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE BESYLATE 2.5 MG TAB has been published 135 times since Apr 24, 2024, and over the history we have for it it has risen 11.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0113 per EA
All-time high$0.0121 (Sep 11, 2024)
All-time low$0.0085 (Nov 20, 2024)
52-week high$0.0114
52-week low$0.0102
Median price$0.0108
Average price$0.0106
Largest weekly change+34.0% (Aug 21, 2024)
Weeks tracked135
Tracking sinceApr 24, 2024

Price History

1W

+2.4%

1M

+6.7%

3M

+10.2%

6M

-0.4%

1Y

+5.1%

3Y

N/A

5Y

N/A

All

+11.7%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of AMLODIPINE BESYLATE 2.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE BESYLATE 2.5 MG TAB, manufactured by Exelan Pharmaceuticals Inc., is $0.0113 per EA (NDC 76282050790), effective Nov 18, 2026.

How has the price of AMLODIPINE BESYLATE 2.5 MG TAB changed over time?

Over the history we have for it, the NADAC for AMLODIPINE BESYLATE 2.5 MG TAB has risen 11.7%. It has been tracked across 135 weekly CMS publications since Apr 24, 2024.

What are the highest and lowest recorded NADAC prices for AMLODIPINE BESYLATE 2.5 MG TAB?

Since Apr 24, 2024, the NADAC for AMLODIPINE BESYLATE 2.5 MG TAB has ranged from a low of $0.0085 (Nov 20, 2024) to a high of $0.0121 (Sep 11, 2024), with a median of $0.0108 per EA.

Are there cheaper alternatives to AMLODIPINE BESYLATE 2.5 MG TAB?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMLODIPINE BESYLATE 2.5 MG TAB, is $0.0111 per EA — about 2% below AMLODIPINE BESYLATE 2.5 MG TAB.

Who manufactures AMLODIPINE BESYLATE 2.5 MG TAB?

AMLODIPINE BESYLATE 2.5 MG TAB (NDC 76282050790) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.